A new study has shown how machine learning can be used to simulate drug–target binding affinity to identify potential new drugs. Two virtual drug discovery methods are already in use: high-throughput ...
SOMERVILLE, Mass., October 23, 2025 – Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a ...
Publication illustrates foundational innovation that has defined the company’s advanced platform integrating high-dimensional transcriptomics and AI predictive modeling for drug discovery Cellarity, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback